# Cabergoline As An Adjuvant To Clomiphene Citrate For Management Of Unexplained Infertility

> **NCT03549741** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Assiut University** · enrollment: 120 (estimated)

## Conditions studied

- Infertility

## Interventions

- **DRUG:** Clomiphene Citrate 50mg
- **DRUG:** Cabergoline Oral Tablet
- **DRUG:** Placebo Oral Tablet

## Key facts

- **NCT ID:** NCT03549741
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-07
- **Primary completion:** 2019-06
- **Final completion:** 2019-11
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2018-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03549741

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03549741, "Cabergoline As An Adjuvant To Clomiphene Citrate For Management Of Unexplained Infertility". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03549741. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*